STOCK TITAN

MetLife's 401(k) Trust and Investment Accounts Trim $180K in Stock Holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

MetLife has filed a Form 144 notice for the proposed sale of 1,024 shares of common stock with an aggregate market value of $81,879.04. The sale is planned to be executed through Goldman Sachs on the NYSE, with an approximate sale date of June 27, 2025.

The securities to be sold were acquired in three separate purchases during 2013:

  • 31 shares from Deutsche Bank on January 31, 2013
  • 902 shares from Goldman Sachs on March 13, 2013
  • 91 shares from Goldman Sachs on May 15, 2013

Recent trading activity shows that related entities have sold 1,256 shares in the past three months, totaling approximately $99,076.70 in gross proceeds. The filing was made by the MetLife 401(k) Plan Trust, which maintains an affiliate discretionary manager relationship with the issuer. The company has 671,297,826 shares outstanding.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many MET shares are being sold according to the June 2025 Form 144 filing?

According to the Form 144 filing, 1,024 shares of MetLife (MET) common stock are proposed to be sold through Goldman Sachs, with an aggregate market value of $81,879.04. The sale is expected to take place on the NYSE around June 27, 2025.

Who is selling MET shares in this Form 144 filing?

The MetLife 401(k) Plan Trust is selling the shares, acting as an affiliate discretionary manager. The filing was signed by Mirsad Usejnoski and the shares will be sold through Goldman Sachs at 200 West Street, New York.

What recent MET stock sales were disclosed in the three months prior to this Form 144?

In the three months prior to this filing, there were several sales of MET stock: 221 shares by Separate Account II on 6/13/2025, and on 6/20/2025: 547 shares by MetLife 401k Plan Trust, 360 shares by Separate Account SPI, 101 shares by Separate Account II, and 27 shares by Separate Account 149, totaling 1,256 shares.

When were the MET shares being sold originally acquired?

The shares being sold were acquired in three separate purchases in early 2013: 31 shares from Deutsche Bank on January 31, 2013, 902 shares from Goldman Sachs on March 13, 2013, and 91 shares from Goldman Sachs on May 15, 2013. All purchases were made with cash payment.

What is the total number of MET shares outstanding as of June 2025?

According to the Form 144 filing, MetLife (MET) had 671,297,826 shares outstanding at the time of the filing in June 2025.
MetLife

NYSE:MET

MET Rankings

MET Latest News

MET Latest SEC Filings

MET Stock Data

51.33B
550.65M
0.25%
91.63%
1.37%
Insurance - Life
Life Insurance
Link
United States
NEW YORK